SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-20-000222
Filing Date
2020-06-12
Accepted
2020-06-12 18:17:25
Documents
1
Period of Report
2020-06-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 19576
  Complete submission text file 0000914190-20-000222.txt   21098
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 BETHESDA METRO CENTER STE 700 C/O REGENERX BIOPHARMACEUTICALS INC BETHESDA MD 20814
Business Address
MCNAY JOSEPH C (Reporting) CIK: 0001257674 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 20961416